Big Technology

Big Technology

Share this post

Big Technology
Big Technology
Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide
Copy link
Facebook
Email
Notes
More
Press Releases

Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide

Led by Osage Venture Partners, Debiopharm, HearstLab, and Golden Seeds

Feb 06, 2024
∙ Paid

Share this post

Big Technology
Big Technology
Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide
Copy link
Facebook
Email
Notes
More
Share

SAN FRANCISCO, CA -- Strategikon, provider of cloud-based solutions that optimize and accelerate the budgeting, planning, outsourcing, and vendor management of clinical trials, has recently closed an over-subscribed $7.0M Series A1 financing round. This achievement underscores the high demand and investor confidence in Strategikon's pioneering technolog…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Alex Kantrowitz
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More